
|Articles|September 11, 2015
Priority Review to Multiple Myeloma, Lung Cancer Drugs Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/priority-review-to-multiple-myeloma-lung-cancer-dr" target="_blank">View the story "Priority Review to Multiple Myeloma, Lung Cancer Drugs Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
3
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
4
Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer
5




























































































































